Levodopa-Responsive Parkinsonizm PTEN Varyantı ile İlişkili İzole Üst Limb Tremor tarafından Önlendi.
Levodopa-Responsive Parkinsonism Preceded by Isolated Upper Limb Tremor Associated with PTEN Variant.
DOI: 10.1002/mdc3.70844PMID: 42806734
Levodopa-Responsive Parkinsonism Preceded by Isolated Upper Limb Tremor Associated with PTEN Variant.
DOI: 10.1002/mdc3.70844PMID: 42806734
Nutritional education program counseling based on the Mediterranean diet on intestinal constipation in people with Parkinson's disease: a randomized clinical trial.
DOI: 10.1016/j.parkreldis.2026.109003PMID: 42815344
Tonic-dominant sleep bruxism in multiple system atrophy: A polysomnographic comparison with Parkinsonian-related disorders.
DOI: 10.1016/j.parkreldis.2026.109002PMID: 42815345
Oleandrin and PBI-05204 for Neuroprotection in Alzheimer's Disease, Parkinson's Disease, and Stroke: Preclinical Mechanisms, Blood-brain Barrier Penetration, and Clinical Translation Perspectives.
DOI: 10.2174/0113895575485020260907153210PMID: 42816980
Quantitative FP-CIT PET analysis of dopaminergic degeneration in isolated REM sleep behavior disorder and early Parkinson's disease.
DOI: 10.1016/j.sleep.2026.109292PMID: 42826683
MRI-derived choroid plexus volume and longitudinal cognitive decline in Parkinson's disease.
DOI: 10.1016/j.parkreldis.2026.109006PMID: 42837908
Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits.
DOI: 10.1016/j.parkreldis.2026.109001PMID: 42844068
Smartphone placement recognition during walking: External validation and performance determinants.
DOI: 10.1016/j.gaitpost.2026.110649PMID: 42925673
Progressive Cognitive Decline and Pyramidal Signs in a Patient With a Novel Homozygous c.395A>T; p.Lys132Met Mutation in CHCHD2.
DOI: 10.1002/ccr3.73644PMID: 42812516
Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO-B Inhibitory Potential for Parkinson's Disease.
DOI: 10.1021/acsomega.6c07002PMID: 42890068
Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease
Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson's Disease.
DOI: 10.3390/medsci14060608PMID: 42930527
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.